Watts Annabelle M, West Nicholas P, Cripps Allan W, Smith Pete K, Cox Amanda J
School of Medical Science, Griffith University, Southport, Queensland, Australia.
Menzies Health Institute of Queensland, Griffith University, Southport, Queensland, Australia.
Int Arch Allergy Immunol. 2018;177(1):29-34. doi: 10.1159/000489609. Epub 2018 Jun 19.
Investigations of gene expression in allergic rhinitis (AR) typically rely on invasive nasal biopsies (site of inflammation) or blood samples (systemic immunity) to obtain sufficient genetic material for analysis. New methodologies to circumvent the need for invasive sample collection offer promise to further the understanding of local immune mechanisms relevant in AR.
A within-subject design was employed to compare immune gene expression profiles obtained from nasal washing/brushing and whole blood samples collected during peak pollen season. Twelve adults (age: 46.3 ± 12.3 years) with more than a 2-year history of AR and a confirmed grass pollen allergy participated in the study. Gene expression analysis was performed using a panel of 760 immune genes with the NanoString nCounter platform on nasal lavage/brushing cell lysates and compared to RNA extracted from blood.
A total of 355 genes were significantly differentially expressed between sample types (9.87 to -9.71 log2 fold change). The top 3 genes significantly upregulated in nasal lysate samples were Mucin 1 (MUC1), Tight Junction Protein 1 (TJP1), and Lipocalin-2 (LCN2). The top 3 genes significantly upregulated in blood samples were cluster of differentiation 3e (CD3E), FYN Proto-Oncogene Src Family Tyrosine Kinase (FYN) and cluster of differentiation 3d (CD3D).
Overall, the blood and nasal lavage samples showed vastly distinct gene expression profiles and functional gene pathways which reflect their anatomical and functional origins. Evaluating immune gene expression of the nasal mucosa in addition to blood samples may be beneficial in understanding AR pathophysiology and response to allergen challenge.
变应性鼻炎(AR)的基因表达研究通常依赖侵入性鼻活检(炎症部位)或血液样本(全身免疫)来获取足够的遗传物质进行分析。规避侵入性样本采集需求的新方法有望进一步加深对AR相关局部免疫机制的理解。
采用受试者自身对照设计,比较在花粉高峰期采集的鼻腔冲洗/刷取样本和全血样本的免疫基因表达谱。12名有超过2年AR病史且确诊对草花粉过敏的成年人(年龄:46.3±12.3岁)参与了该研究。使用包含760个免疫基因的检测板,通过NanoString nCounter平台对鼻腔灌洗/刷取细胞裂解物进行基因表达分析,并与从血液中提取的RNA进行比较。
样本类型之间共有355个基因存在显著差异表达(log2倍变化为9.87至-9.71)。鼻腔裂解物样本中显著上调的前3个基因是粘蛋白1(MUC1)、紧密连接蛋白1(TJP1)和脂质运载蛋白2(LCN2)。血液样本中显著上调的前3个基因是分化簇3e(CD3E)、FYN原癌基因Src家族酪氨酸激酶(FYN)和分化簇3d(CD3D)。
总体而言,血液和鼻腔灌洗样本显示出截然不同的基因表达谱和功能基因途径,这反映了它们的解剖学和功能起源。除血液样本外,评估鼻黏膜的免疫基因表达可能有助于理解AR的病理生理学及对过敏原激发的反应。